TrialClinical cancer research : an official journal of the American Association for Cancer Research2023

Phase II Trial of Pembrolizumab and Anti-CD3 x Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer.

Ulka N Vaishampayan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.